CXCR3 enables recruitment and site-specific bystander activation of memory CD8+ T cells

by Nicholas J. Maurice, M. Juliana McElrath, Erica Andersen-Nissen, Nicole Frahm, Martin Prlic
Published 2019-11-01

Dynamics of viral evolution and CTL responses in HIV-1 infection.

by Yi Liu, John P McNevin, Sarah Holte, M Juliana McElrath, James I Mullins
Published 2011-01-01

Machine learning identifies molecular regulators and therapeutics for targeting SARS‐CoV2‐induced cytokine release

by Marina Chan, Siddharth Vijay, John McNevin, M Juliana McElrath, Eric C Holland, Taranjit S Gujral
Published 2021-09-01

Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.

by Michael Vaine, Shixia Wang, Qin Liu, James Arthos, David Montefiori, Paul Goepfert, M Juliana McElrath, Shan Lu
Published 2010-11-01

Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based model...

by Yunda Huang, Ann Duerr, Nicole Frahm, Lily Zhang, Zoe Moodie, Steve De Rosa, M Juliana McElrath, Peter B Gilbert
Published 2014-01-01

Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans.

by Samuel O Pine, James G Kublin, Scott M Hammer, Joleen Borgerding, Yunda Huang, Danilo R Casimiro, M Juliana McElrath
Published 2011-04-01

The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier.

by Maria P Lemos, Javier R Lama, Shelly T Karuna, Youyi Fong, Silvia M Montano, Carmela Ganoza, Raphael Gottardo, Jorge Sanchez, M Juliana McElrath
Published 2014-01-01

In Situ Staining and Laser Capture Microdissection of Lymph Node Residing SIV Gag-Specific CD8+ T cells--A Tool to Interrogate a Functional Immune Response Ex Vivo.

by Annelie Tjernlund, Adam Burgener, Jessica M Lindvall, Tao Peng, Jia Zhu, Lars Öhrmalm, Louis J Picker, Kristina Broliden, M Juliana McElrath, Lawrence Corey
Published 2016-01-01

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.

by Rephaim Mpofu, Kennedy Otwombe, Koleka Mlisana, Maphoshane Nchabeleng, Mary Allen, James Kublin, M Juliana McElrath, Linda-Gail Bekker, Gavin Churchyard, Glenda Gray, Fatima Laher
Published 2021-01-01

Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054).

by Laurence Peiperl, Cecilia Morgan, Zoe Moodie, Hongli Li, Nina Russell, Barney S Graham, Georgia D Tomaras, Stephen C De Rosa, M Juliana McElrath, NIAID HIV Vaccine Trials Network
Published 2010-10-01

Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study.

by Fusheng Li, Adam C Finnefrock, Sheri A Dubey, Bette T M Korber, James Szinger, Suzanne Cole, M Juliana McElrath, John W Shiver, Danilo R Casimiro, Lawrence Corey, Steven G Self
Published 2011-01-01

Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine...

by Andrew Fiore-Gartland, Bryce A Manso, David P Friedrich, Erin E Gabriel, Greg Finak, Zoe Moodie, Tomer Hertz, Stephen C De Rosa, Nicole Frahm, Peter B Gilbert, M Juliana McElrath
Published 2016-01-01

Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.

by Stephen A Migueles, Julia E Rood, Amy M Berkley, Tiffany Guo, Daniel Mendoza, Andy Patamawenu, Claire W Hallahan, Nancy A Cogliano, Nicole Frahm, Ann Duerr, M Juliana McElrath, Mark Connors
Published 2011-02-01

Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.

by Cheng Cheng, Lingshu Wang, Jason G D Gall, Martha Nason, Richard M Schwartz, M Juliana McElrath, Steven C DeRosa, John Hural, Lawrence Corey, Susan P Buchbinder, Gary J Nabel
Published 2012-01-01

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination

by Cheng Cheng, LingShu Wang, Jason G. D. Gall, Martha Nason, Richard M. Schwartz, M. Juliana McElrath, Steven C. DeRosa, John Hural, Lawrence Corey, Susan P. Buchbinder, Gary J. Nabel
Published 2012-01-01

HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1.

by Tomer Hertz, Hasan Ahmed, David P Friedrich, Danilo R Casimiro, Steven G Self, Lawrence Corey, M Juliana McElrath, Susan Buchbinder, Helen Horton, Nicole Frahm, Michael N Robertson, Barney S Graham, Peter Gilbert
Published 2013-01-01

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.

by Cheng Cheng, LingShu Wang, Jason G. D. Gall, Martha Nason, Richard M. Schwartz, M. Juliana McElrath, Steven C. DeRosa, John Hural, Lawrence Corey, Susan P. Buchbinder, Gary J. Nabel
Published 2012-01-01

RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial

by Gemma Moncunill, Gemma Moncunill, Gemma Moncunill, Stephen C. De Rosa, Stephen C. De Rosa, Aintzane Ayestaran, Augusto J. Nhabomba, Maximillian Mpina, Kristen W. Cohen, Chenjerai Jairoce, Tobias Rutishauser, Tobias Rutishauser, Joseph J. Campo, Joseph J. Campo, Jaroslaw Harezlak, Héctor Sanz, Núria Díez-Padrisa, Nana Aba Williams, Daryl Morris, John J. Aponte, Clarissa Valim, Clarissa Valim, Claudia Daubenberger, Claudia Daubenberger, Carlota Dobaño, Carlota Dobaño, M. Juliana McElrath, M. Juliana McElrath
Published 2017-08-01

MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load.

by Holly Janes, Nicole Frahm, Allan DeCamp, Morgane Rolland, Erin Gabriel, Julian Wolfson, Tomer Hertz, Esper Kallas, Paul Goepfert, David P Friedrich, Lawrence Corey, James I Mullins, M Juliana McElrath, Peter Gilbert
Published 2012-01-01

A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.

by Laura Pattacini, Gregory J Mize, Jessica B Graham, Tayler R Fluharty, Tisha M Graham, Karen Lingnau, Benjamin Wizel, Beatriz Perdiguero, Mariano Esteban, Giuseppe Pantaleo, Mingchao Shen, Gregory A Spies, M Juliana McElrath, Jennifer M Lund
Published 2012-01-01